ESB-Biomaterials Journal Joint Session: Meet the Editor Session

Tuesday, 7 September 2021, 4:15 PM - 5:15 PM (CEST)

Description:

The flagship journal Biomaterials invites you to join the „Meet the Editor Session“ where you have the opportunity to communicate with editors of the journal and ask questions about being the author, reviewer, or any other questions you have about the journal.

The session will feature a panel of Biomaterials editors who will discuss the specific goals and objectives and the recent performance of the journal. Open and moderated discussion will address the process of writing and submitting to the journal, the critical factors that shape editorial decisions on submitted manuscripts etc.

Chairs:

Professor Kam W. Leong, PhD – Editor in Chief | Columbia University Department of Biomedical Engineering, USA

Professor Hai-Quan Mao, PhD – Associate Editor | Johns Hopkins University, USA

Professor Ankur Singh, PhD – Associate Editor | Georgia Institute of Technology Wallace H Coulter Department of Biomedical Engineering, USA

Dr Ana Paula Pêgo, PhD – Associate Editor | i3S/INEB, University of Porto, Portugal

Speaker:

Professor Abhay Pandit, PhD – Associate Editor | National University of Ireland Galway, Ireland

Schedule:

4:15 PM – 4:25 PM – “Biomaterials Journal”, Abhay Pandit

4:25 PM – 4:35 PM “How to Review for Biomaterials”, Abhay Pandit

4:35 PM – 5:15 PM Questions and Answers

Kam W. Leong, Prof.

Editor in Chief | Columbia University Department of Biomedical Engineering, USA

Kam W. Leong holds the James B. Duke Professor of Biomedical Engineering in the Pratt School of Engineering of Duke University, at which he also holds a joint appointment in the Department of Surgery of the School of Medicine. He received his undergraduate degree in Chemical Engineering from the University of California at Santa Barbara and his PhD, also in Chemical Engineering, from the University of Pennsylvania. He then ventured into drug delivery research as a postdoctoral fellow in the laboratory of Professor Robert Langer at MIT, where he helped develop the biodegradable polyanhydrides as a drug carrier for brain tumor therapy.

After his training at MIT, he joined the faculty in the Department of Biomedical Engineering at The Johns Hopkins School of Medicine, and rose through the rank to become a full professor in 1998. While based at Johns Hopkins, he served as a Program Director in the Institute of Materials Research and Engineering in Singapore to help develop biomaterials research in the Institute from 1998-2004. Around the same time, he also directed a lab in Johns Hopkins Singapore on Therapeutics and Tissue Engineering. He moved to Duke University in 2006 to join the Department of Biomedical Engineering, focusing on the development of nanotherapeutics. In particular, his research concentrates on understanding and exploiting the interactions of cells with nanostructures for therapeutic applications. Discrete nanostructures in the form of multi-functional nanoparticles are applied to deliver drugs, antigen, protein, siRNA, and DNA to cells for drug, gene, and immunotherapy. Continuous nanostructures in the form of electrospun nanofiber and imprinted nanopattern are applied to influence cellular behavior, including expansion of various stem cells. The major research projects of his lab are linked by innovative design of polymeric biomaterials and an effort to understand the mechanism of cellular interaction with nanomaterials.

Kam W. Leong serves on the editorial boards of major journals in the fields of biomaterials, drug delivery, nanomedicine, and gene and cell therapy. He owns more than 40 issued patents, and has published over 230 peer-reviewed research manuscripts. His research was recognized by the Young Investigator Research Achievement Award of Controlled Release Society in 1994, and several awards by the same Society on Excellence in Guidance of Graduate Student Research. He also received the Stansell Family Distinguished Research Award from Duke University in 2010.

Hai-Quan Mao, Prof.

Associate Editor | Johns Hopkins University, USA

Hai-Quan Mao is the associate director of the Institute of NanoBioTechnology (INBT) and a professor of materials science and engineering at Johns Hopkins University. He holds a joint appointment in the Translational Tissue Engineering Center and the Department of Biomedical Engineering at the School of Medicine. Prof. Mao’s research focuses on engineering novel nanomaterials for regenerative medicine and therapy delivery applications. He has developed nanofiber scaffolds from synthetic and natural biomaterials for liver tissue engineering; stem cell expansion and differentiation; and soft tissue regeneration. He also has discovered a synergistic effect between nanofiber topography and biochemical cues on the proliferation of human hematopoietic stem and progenitor cells (HSCs); invented a more efficient HSC expansion method that can enable various HSC-based cellular therapies; engineered different methods for promoting lineage-specific differentiation of neural (crest) stem cells; and developed tailored, nanofiber-based scaffolds for vascular engineering, skeletal muscle regeneration, spinal cord repair and peripheral nerve regeneration. His contributions in therapeutic engineering include understanding the assembly mechanism of nanoparticles from the polyelectrolyte complex of plasmid DNA, RNA or protein therapeutics with charged polymer carriers; engineering DNA nanoparticles with tunable shape and uniformity that mimic natural viral particles; the development of scalable production methods for these therapeutic nanoparticles; and their applications in local and systemic delivery of macromolecular therapeutics and vaccines.

Prof. Mao also serves on the editorial board of ACS Biomaterials Science & Engineering and Journal of Materials Chemistry B. He holds 28 U.S. patents and has published more than 190 peer-reviewed research manuscripts. He has been elected a Fellow of the Royal Society of Chemistry and the American Institute for Medical and Biological Engineering, and a senior member of the National Academy of Inventors. He was the recipient of the Young Investigator Award at the National University of Singapore in 2002 and the National Science Foundation faculty CAREER Award in 2008.

Ankur Singh, Prof.

Associate Editor | Georgia Institute of Technology Wallace H Coulter Department of Biomedical Engineering, USA

Ankur Singh is a Woodruff Faculty Fellow and an Associate Professor of George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology and Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Before Georgia Tech, he was an Associate Professor at Cornell University, where he served on the Center for Immunology’s Executive Council and Cornell’s academic integration advisory council. He was the Associate Director of Cornell’s NIH Immunoengineering training grant. His laboratory develops immune organoids and enabling technologies to understand healthy and diseased immune cells and translate therapeutics. He has received funding from the National Institute of Health, National Science Foundation, Wellcome Leap HOPE, Department of Defense, Defense Threat Reduction Agency, and Lymphoma and Leukemia Society. He has published >60 articles in peer-reviewed journals, including Nature Methods, Nature Materials, Nature Nanotechnology, Science Advances, Nature Communications, Nature Reviews Materials, Nature Protocols, PNAS, Blood, Advanced Functional Materials, and Advanced Materials. He has written multiple editorials for Science Translational Medicine. He is a recipient of the NSF CAREER, Society for Biomaterials Young Investigator Award, CMBE Young Innovator Award, CMBE Rising Star Award, 3M Faculty Award, DoD Career award, Cornell’s Teaching Excellence Award, and Cornell’s Research Excellence Award. His immune organoids were identified among the Top 100 Discoveries of 2015 by Discover Magazine. He is the Founder and past-Chair of the Immune Engineering SIG at the Society for Biomaterials and Controlled Release Society. He serves on the editorial board of Biomaterials, Advanced NanoBiomed Research, Cellular and Molecular bioengineering, Scientific Reports, and J of Immunology and Regenerative Medicine journals.

Ana Paula Pêgo, Prof.

Associate Editor | i3S/INEB, University of Porto, Portugal

Ana Paula Pêgo got her Ph.D. in Polymer Chemistry and Biomaterials from the University of Twente, the Netherlands, in 2002. In 2003 she moved to INEB – Instituto de Engenharia Biomédica, where she became a Principal Investigator in 2012. In 2015, INEB joined the i3S – Instituto de Investigação e Inovação em Saúde (Universidade do Porto), where Ana Paula Pêgo leads the nanoBiomaterials for Targeted Therapies (nBTT) Group.

By using nanomedicine strategies the nBTT Group, aims at providing in situ and in a targeted manner the required signals to promote nervous tissue regeneration. The research on new biomaterials for application in neurosciences includes the development of new polymers for the design of alternative vectors to viruses for efficient nucleic acid delivery, the preparation of nerve grafts for spinal cord injury treatment and the design of brain tissue engineered platforms. Societal and ethical issues that concern Regenerative Medicine and NanoMedicine are also topics in which Ana Paula Pêgo is involved.

She has been appointed the Scientific Director of the Bioimaging Centre for Biomaterials and Regenerative Therapies of INEB and she is an Invited Associate Professor at the Instituto de Ciências Biomédicas Abel Salazar (ICBAS) and at the Faculty of Engineering (FEUP) of the University of Porto.

Currently Ana Paula Pêgo is a member of the Board of Directors of i3S, being the Head of Strategy & Creation of Value Unit, is the Secretary of the Council of the European Society for Biomaterials (ESB), serves as an Associate Editor of Biomaterials (Elsevier journal) and is part of the Board of Reviewing Editors of Science (AAAS).

She received several distinctions that include the Neuroscience Awards by SCML (the most prestigious national award in the field) and the Young Scientist Award 2015 at the 5th China-Europe Symposium on Biomaterials and Regenerative Medicine (Hangzhou, China).

Dr. Pêgo has published more that 80 peer-reviewed articles in leading international journals in the biomaterials, nanotechnology and nanomedicine fields; authored 7 book chapters and is an inventor in 3 active patents (one licensed to Pharma) and 1 patent.

She is very proud of her mentoring/supervision duties actively contributing to the training of the next generation of bioengineers. To date, 22 PhD students, 7 post-doc and 47 MSc students are or have been supervised by her.

Abhay Pandit, Prof.

Associate Editor | National University of Ireland Galway, Ireland

Professor Pandit is the Director of the Centre for Research in Medical Devices (CÚRAM).

Prof. Pandit’s research integrates material science and biological paradigms in developing solutions for chronic diseases. Prof Pandit has developed next generation reservoir delivery vehicles with high payload capacity, programmable degradation profiles and inbuilt gradients of physical, chemotropic and protective cues which facilitate spatiotemporal localised sustained delivery of multiple biomolecules to target injury mechanisms at the molecular and cellular levels.

The biomaterial platforms have been validated to act as inductive templates for constructive remodelling and as templates for the induction of de novo functional, site-appropriate, tissue formation. These platforms have been developed for neural, musculoskeletal and cardiovascular clinical targets with numerous other targets currently under development. 

Prof. Pandit has received numerous awards and distinctions. He was inducted as an International Fellow in Biomaterials Science and Engineering by the International Union of Societies for Biomaterials Science and Engineering and elected as a Fellow of the Tissue Engineering and Regenerative International Society. He was also elected to the American Institute of Medical and Biological Engineering (AIMBE) College of Fellows in recognition of his outstanding contributions to establishing a national centre which will develop transformative device-based solutions to treat global chronic diseases.  He is the first Ireland-based academic to be bestowed with these honors. He has been an elected member on the Council for both the Tissue Engineering and Regenerative Medicine International Society and European Society for Biomaterials Society. Prof Pandit has published more than 250 papers in peer-reviewed journals, filed numerous patent applications and has licensed four technologies to medical device companies.  In recognition of his track record in technology transfer Prof. Pandit secured the Academic/Emerging Medical technology Company of the Year – Silver Award for 2013 awarded by the Irish Medical Devices Association, Enterprise Ireland and IDA Ireland. He has co-ordinated four EU grants to date and has generated research contracts from industry and government funding agencies totalling €90M.

Current information

The access link to the virtual conference platform was sent to all registered participants on Thursday, 2 September 2021. Please also check your spam folder.

If you have already activated your account with your personal access link, you can enter the platform here:

Guidelines ESB
Guidelines Gather.town
Guidelines NANOSTEM
Guidelines SIBB
Guidelines TRS
All presenters of ESB 2021 are welcome to use the following image as background for the video in their presentation.

ESB 2021 Abstract Book

ESB 2021 Abstract Book for Download (PDF 70 MB)

Important Dates

Deadline Early Bird Registration
Virtual conference
24 August 2021

Late Registration
Virtual conference
from 25 August 2021

ESB 2021
5–9 September 2021
as fully virtual conferencel

Biomechanics part:
9 September 2021

Conference Status with respect to the Coronavirus pandemic

Taking into consideration the health and safety of all presenters, exhibitors and attendees, and the importance of assuring the quality of the Conference Program, the Organising Committee has taken the difficult decision to move ESB2021 to a fully virtual format, from September 5-9, 2021.

More information

Organizer

esb-300x154-1.jpg

Contact

logo_kit_gross.png

K.I.T. Group GmbH Dresden
Bautzner Str. 117-119
01099 Dresden, Germany